ESR1 and breast cancer: While none of these pathways passed a false discovery rate threshold of 0.25 after adjusting for multiple comparisons likely due to relatively small numbers of genes, it is interesting to note that biological pathways involving ERα cell cycle regulation and cell migration were only affected by endoxifen in breast cancer cells expressing ERβ (Table 1).